Additionally, Mucin 15 (MUC15), which is downregulated in PCa, represents a potential therapeutic target by inhibiting EMT and cancer stemness through the GSK3β/β-catenin signaling pathway (44). Here, GSK3B is linked to posterior cortical atrophy.